FILRA
Active Ingredient: FILGRASTIM
Product Overview
About FILRA
FILRA is a medication containing the active ingredient Filgrastim, a recombinant DNA-derived human granulocyte colony-stimulating factor (G-CSF). It is used to stimulate the production of white blood cells, specifically neutrophils, in patients undergoing chemotherapy, bone marrow transplantation, or other treatments that suppress the bone marrow.
Key Benefits & Uses
- Reduces the incidence and duration of febrile neutropenia, a condition characterized by fever and low neutrophil count, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.
- Decreases the need for antibiotic treatment and hospitalization due to febrile neutropenia.
- Supports the recovery of neutrophil count in patients with severe chronic neutropenia.
Active Ingredient & Action
Filgrastim works by binding to specific receptors on the surface of bone marrow cells, stimulating the production and release of neutrophils into the bloodstream. This helps to restore the body's natural defense against infections and promotes recovery from chemotherapy-induced neutropenia.
Important Notes
FILRA should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects. Patients with a history of allergic reactions to Filgrastim or other G-CSF products should not use FILRA. Common side effects include bone pain, muscle pain, and injection site reactions.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
